Tzield® is demonstrated to delay by a median of 2 years the onset of Stage 3 type 1 diabetes in patients 8 years of age and older currently with Stage… Read More
Eupraxia continues to observe positive treatment outcomes in its ongoing Phase 1b/2a trial, including for the first time clinical responses measured 9 months after dosing with EP-104GI At 9 months… Read More
The University of British Columbia’s School of Biomedical Engineering (SBME) is partnering to launch a new hands-on training opportunity in biomanufacturing that will help students gain practical skills for careers in B.C.’s rapidly growing biotechnology… Read More
Internationally Recognized Lawyer Launches AMR Law to Support the Future of AI, Technology, and Life Sciences VANCOUVER, BC — On May 1, 2025, Three-time winner of Canada’s Top 100 Most… Read More
Combines cancer biology, genetics, medicinal chemistry, and biologics research and development experience to rapidly advance a broad pipeline of preclinical oncology programs against genetically-defined cancers Licenses Repare’s SNIPRx®, SNIPRx-surf, and… Read More
